비교리스트

 카트 문의
시장보고서
상품코드
1408651

세계의 완제(Fill Finish) 제조 시장 : 규모, 예측, 세계 및 지역별 점유율, 동향, 성장 기회 분석 - 제품별, 양식별, 최종사용자별

Fill Finish Manufacturing Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, Modality, and End User
발행일: | 리서치사: The Insight Partners | 페이지 정보: 영문 182 Pages | 배송안내 : 즉시배송

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 완제(Fill Finish) 제조 시장 규모는 2022년 87억 500만 달러로 2022년부터 2030년까지 연평균 8.9% 성장하여 2030년에는 171억 6,500만 달러에 달할 것으로 예상됩니다.

"완제(fill/finish)"라는 용어는 제조 공정의 마지막 단계인 충전과 마무리를 의미합니다. 제약 산업에서 충진은 의약품을 용기에 넣고 닫는 것을 의미하며, 마무리는 의료 용품 및 용기의 멸균 및 표준화를 의미합니다.

비경구용 프리필드 시린지의 채택 확대가 완제 제조 시장의 성장을 견인할 것입니다.

비경구 투여는 즉각적인 면역 반응을 자극하고 약물의 완전한 생체 이용률을 보장하기 위해 선택되는 가장 두드러진 경로 중 하나입니다. 비경구용 의약품의 개발과 시장 출시가 꾸준히 증가함에 따라, 투여의 용이성을 약속하는 첨단적이고 비용 효율적인 약물전달 장비에 대한 수요가 증가하고 있습니다. 기존 전달 시스템 대비 프리필드 시린지의 장점으로는 간편한 투여, 안전성 향상, 정확한 투여, 오염 위험 감소 등이 있습니다. 약물전달 장치 중 프리필드 시린지는 가장 빠르게 성장하고 있는 1차 포장 형태 중 하나이며, 투약용으로 설계되었습니다. 지난 10년 동안 비경구 약물(특히 일부 생물학적 제제의 도입)의 개발이 분명히 증가하여 프리필드 시린지의 소비가 약 3 배 증가했습니다. 프리필드 시린지에 대한 지속적인 선호는 이러한 제품의 안전성과 사용 편의성에 기인합니다. 최신 제품들은 투약 실수, 막힘, 액체 누출(예: 혈관 외 누출), 정맥 염증(정맥염)을 줄이기 위해 고안되었습니다. 위와 같은 장점 때문에 휴미라, 엠브렐, 아바스틴, 프레브나13, 알프로릭스, 베네픽스 등 일부 주사제, 희석제, 비경구 투여가 필요한 다른 제품들은 미리 채워진 주사기에 포장되어 있습니다.

지난 7년간 북미, 유럽, 아시아태평양을 포함한 다양한 지역에서 약 90개의 프리필드 시린지 포장 의약품이 승인되었습니다. 약물 개발의 임상 단계에 있는 일부 약물은 미리 채워진 주사기와의 조합으로 평가되고 있습니다.

프리필드 시린지에 무균 약물을 충전하는 것은 의약품 제조 공정에서 가장 중요한 단계 중 하나로 간주됩니다. 약리학적 효능과 품질을 유지하고 최종사용자의 안전을 보장하기 위해 적절한 완제 작업은 필연적으로 무균 조건에서 수행됩니다. 프리필드 주사기 충전은 주사기 충전량과 주사기에 채워진 액체와 플런저 바닥 사이의 헤드 공간을 매우 엄격하게 모니터링해야 하기 때문에 복잡한 작업입니다. 또한, 저분자 원료의약품의 복잡성과 생물학적 제제의 다양화로 인해 고도의 무균 충전 마무리 작업에 대한 수요가 증가하고 있습니다.

중소기업과 대기업을 포함한 기업들은 각각의 완제 작업을 위탁 서비스업체에 위탁하고 있습니다. '제10회 바이오의약품 생산능력 및 생산 연례 보고서 및 조사'에 따르면, 생물학적 제제 제조업체는 완제 작업의 30% 이상을 아웃소싱하고 있는 것으로 확인되었습니다. 프리필드 시린지 수요의 증가와 완제 공정의 복잡성으로 인해 이러한 작업의 아웃소싱은 앞으로 더욱 증가할 가능성이 높습니다. 전 세계적으로 100개 이상의 업체가 프리필드 시린지 제조업체를 위해 완제 서비스를 제공하고 있습니다. 의약품 수요 증가에 대응하기 위해 서비스 제공업체들은 기존 인프라와 역량 확대에 적극적으로 투자하고 있으며, 지난 몇 년 동안 서비스 계약을 통해 고객층도 확대했습니다. 전 세계 R&D 파이프라인에 있는 의약품 후보물질의 약 55%가 주사제이기 때문에 프리필드 시린지 제조업체와 관련 서비스 제공업체들의 사업도 성장하고 있으며, COVID-19 사태로 인해 전 세계적으로 백신 개발이 활발해지면서 프리필드 시린지에 대한 수요가 크게 증가했습니다. 크게 증가했습니다. 이처럼 비경구 투여용 프리필드 시린지 채택이 증가하면서 완제 제조 시장을 주도하고 있습니다.

완제 제조 시장은 제품, 양식 및 최종사용자에 따라 세분화됩니다. 제품을 기준으로 완제 제조 시장은 소모품 및 기구로 분류됩니다. 소모품 부문은 다시 프리필드 시린지, 유리/플라스틱 바이알, 카트리지, 기타로 세분화됩니다. 모달리티별로 완제 제조 시장은 재조합 단백질, 단클론 항체, 백신, 세포 및 생물학적 치료, 유전자 치료, 기타로 분류됩니다. 최종사용자에 따라 완제 제조 시장은 위탁 생산 기관, 바이오 제약 회사, 기타로 분류됩니다.

지역별로 완제 제조 시장은 북미, 유럽, 아시아태평양, 중동 및 아프리카, 중남미로 나뉩니다. 북미는 완제 제조 시장의 성장에 가장 큰 기여를 하고 있습니다. 캐나다는 바이오 제약 산업이 가장 빠르게 발전하고 있는 국가 중 하나입니다. 다양한 국제 기업들이 캐나다의 바이오 제약 산업에 투자하고 있습니다. 캐나다에서는 바이오 제약 기업의 수가 크게 증가하고 있습니다. 예를 들어, 브리티시컬럼비아주 밴쿠버에는 대부분의 바이오제약 기업이 있으며, 연간 9,030만 달러(1억 2,000만 캐나다 달러)의 수익을 창출하고 있습니다. 국내 바이오 제약사는 전국에 35-40개사가 있습니다. 캐나다의 바이오제약 기업으로는 Inex Pharmaceuticals, Quest Vitamins, StressGen Biotechnologies, Stanley Pharmaceuticals, QLT Phototherapeutics, Stemcell Technologies 등이 있습니다. 또한, Center for Molecular Medicine and Therapeutics, BC Biotechnology Laboratory, BC Cancer Research Center, Canadian HIV Trials Network, Vaccine Evaluation Center 등 다양한 공공 및 민간 연구기관도 있습니다. 이러한 캐나다의 바이오의약품 산업의 발전은 예측 기간 동안 시장 성장을 촉진할 것으로 보입니다.

아시아태평양은 향후 몇 년 동안 가장 빠르게 성장하는 시장이 될 것으로 예상됩니다. 아시아태평양에서는 중국이 가장 큰 완제 제조 시장입니다. 이 시장의 성장은 주로 중국 내 완제 제조 공정의 기술 발전, 시장 진입 기업의 개척 증가, 바이오 제약 산업의 확장, 만성 질환의 유병률 증가에 기인합니다. 중국에는 500개 이상의 생물학적 제제/바이오의약품 기업이 있습니다. 연구개발에 종사하는 대부분의 기업들은 해외에서 돌아온 귀국자나 유럽과 미국의 합작회사에 의해 설립되었습니다. 추정치에는 차이가 있지만, 분석가들에 따르면 중국 정부는 자금 지원 이니셔티브를 통해 연간 6억 달러 이상을 생명공학 연구개발에 투자하고 있습니다. 중국 국가와 지방 정부도 IT 기업에 투자하는 준 벤처캐피털 기업에 투자하고 있습니다. 시장 기업들은 유기적 및 무기적 성장 전략을 통해 사업을 확장하고 있습니다. 예를 들어, WuXi Biologics는 2022년 6월 중국 우시에 의약품 공장을 설립해 연간 1,700만 개의 프리필드 시린지(PFS) 생산 능력을 확대했습니다. 위탁개발생산기관(CDMO)인 우시바이오가 운영하는 최신 D.P. 시설은 DP5로 불리며, 신뢰할 수 있는 연속 충진 서비스를 위한 첨단 아이솔레이터 충진라인을 갖추고 있습니다. 이를 통해 PFS는 1.25mL, 3mL, 1mL, 1mL 등 다양한 용량 전달 옵션을 제공할 수 있다는 것이 회사 측의 설명입니다.

ClinicalTrails.com, 질병통제예방센터(CDC), 미국 식품의약국(FDA)은 완제 제조 시장에 대한 보고서를 작성할 때 참고한 1차 및 2차 정보 중 일부입니다.

목차

제1장 서론

제2장 주요 요약

  • 주요 인사이트

제3장 조사 방법

  • 조사 범위
  • 2차 조사
  • 1차 조사

제4장 완제(Fill Finish) 제조 시장 상황

  • PEST 분석

제5장 완제 제조 시장 : 주요 산업 역학

  • 완제 제조 시장 : 주요 산업 역학
  • 주요 시장 성장 촉진요인
    • 비경구 투여용 프리필드 시린지 채용 확대
    • 생물학적 제제에 대한 수요 증가
  • 주요 시장 성장 억제요인
    • 바이오의약품 수탁제조 산업의 경쟁 격화
  • 주요 시장 기회
    • 신흥 시장의 낮은 비지니스 비용
  • 주요 향후 동향
    • 무균 완제용 일회용 시스템
  • 성장 촉진요인과 억제요인의 영향

제6장 완제 제조 시장 : 세계 시장 분석

제7장 완제 제조 시장 분석 : 제품

  • 소모품
  • 기기

제8장 완제 제조 시장 분석 : 모달리티

  • 재조합 단백질
  • 단클론항체
  • 백신
  • 세포 치료와 생물학적 치료
  • 유전자 치료
  • 기타

제9장 완제 제조 시장 분석 : 최종사용자

  • 제조수탁기관
  • 바이오의약품 기업
  • 기타

제10장 완제 제조 시장 : 지역별 분석

  • 북미
  • 유럽
  • 아시아태평양
  • 중동 및 아프리카
  • 중남미

제11장 완제 제조 시장 : COVID-19 팬데믹의 영향

  • COVID-19 전후의 영향

제12장 산업 상황

  • 완제 제조 시장의 성장 전략, 2020-2023년
  • 무기적 성장 전략
  • 유기적 성장 전략

제13장 기업 개요

  • IMA Industria Macchine Automatiche SpA
  • Nipro Medical Europe NV
  • Maquinaria Industrial Dara SL
  • Groninger and Co GmbH
  • SGD SA
  • Optima Packaging Group Gmbh
  • NNE AS
  • Stevanato Group SpA
  • Syntegon Technology GmbH
  • West Pharmaceutical Services Inc
  • Gerresheimer AG
  • Schott AG
  • Becton Dickinson and Co

제14장 부록

ksm 24.01.24

The fill-finish manufacturing market is expected to grow from US$ 8.705 billion in 2022 to US$ 17.165 billion by 2030; it is anticipated to record a CAGR of 8.9% from 2022 to 2030.

The term "fill/finish" describes the final steps of the manufacturing process, which are filling and finishing. Filling in the pharmaceutical industry means putting medication into a container and closing it, whereas finishing refers to sterilizing and standardizing medical supplies and containers.

Growing Adoption of Prefilled Syringes for Parenteral Administration drives the growth of the Fill Finish Manufacturing Market.

Parenteral administration is one of the most prominent routes chosen to stimulate immediate immune response and ensure the complete bioavailability of pharmaceutical products. A steady rise in the development and market availability of parenteral drugs has propelled the demand for advanced, cost-effective drug delivery devices that promise ease of administration. The benefits of prefilled syringes over traditional delivery systems include easy administration, improved safety, accurate dosing, and reduced contamination risks. Among drug delivery devices, prefilled syringes represent one of the fastest-growing primary packaging formats, which are designed for dose administration. In the past ten years, there has been an evident increase in the development of parenteral drugs (especially with the introduction of several classes of biologics), which has resulted in approximately three-fold increase in the consumption of prefilled syringes. The sustained preference for the prefilled syringes is attributed to the safety and ease of use of these products. Recent variants are designed with provisions to reduce errors in dosing, risk of occlusions, leakage of fluids (i.e., extravasation), and inflammation of veins (phlebitis). Owing to the benefits mentioned above, several injectable drugs-Humira, Enbrel, Avastin, PREVNAR 13, ALPROLIX, and Benefix, among others-diluents and other products requiring parenteral administration are packaged in prefilled syringes.

Over the past seven years, ~90 drugs have been approved in the prefilled syringe packaging form across different geographies, including North America, Europe, and Asia Pacific. Several drugs in the clinical stages of drug development are being evaluated in combination with prefilled syringes.

The loading of sterile drugs into prefilled syringes is considered one of the most crucial steps in the pharmaceutical production process. Proper fill-finish operations are necessarily carried out under aseptic conditions to maintain pharmacological efficacy and quality and to ensure the safety of end users. The prefilled syringe filling is a complex operation as it requires extremely close monitoring of both the syringe fill volume and the headspace between the liquid filled in the syringe and the bottom of the plunger. In addition, the rise in complexity of small molecule APIs and the increasing diversity of biological drugs contribute to the demand for advanced aseptic fill finish operations.

Companies, including small enterprises and large businesses, outsource their respective fill finish operations to contract service providers. Per the 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, manufacturers of biological have been observed to outsource more than 30% of their fill finish operations. With the rise in the demand for prefilled syringes and the growing complexity of fill finish processes, outsourcing these operations is likely to increase in the future. Over 100 companies across the globe are providing fill finish services for prefilled syringe manufacturers. To cater to the growing demand for pharmaceutical products, service providers are actively investing in expanding their existing infrastructure and capabilities; they have also expanded their clientele through service agreements over the past few years. As injectables account for ~55% of drug candidates in the global R&D pipeline, the businesses of prefilled syringe manufacturers and associated service providers are also growing. Due to the emergence of the COVID-19 crisis, vaccine development initiatives have increased across the globe, which significantly boosted the demand for prefilled syringes. Thus, the rising adoption of prefilled syringes for parenteral administration drives the fill finish manufacturing market.

The fill finish manufacturing market is divided on the basis of product, modality, and end user. Based on product, the fill finish manufacturing market is segmented into consumables and instruments. The consumables segment is further divided into prefilled syringes, glass vials/plastic vials, cartridges, and others. By modality, the fill finish manufacturing market is segmented into recombinant proteins, monoclonal antibodies, vaccines, cell therapies and biological therapies, gene therapies, and others. In terms of end users, the fill finish manufacturing market is classified as contract manufacturing organizations, biopharmaceutical companies, and others.

Based on geography, the fill finish manufacturing market is divided into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America is the most significant contributor to the growth of the fill finish manufacturing market. Canada is among the fastest-developing countries in terms of the biopharmaceutical industry. Various international companies are investing in the Canadian biopharmaceutical industry. In Canada, the number of biopharmaceutical companies is rising significantly. For instance, Vancouver, British Columbia, has the majority of biopharmaceutical companies, which generate US$ 90.3 million (CAD 120 million) revenue annually. There are ~35-40 domestic biopharmaceutical companies across the country. A few of the Canadian biopharmaceutical companies include Inex Pharmaceuticals, Quest Vitamins, StressGen Biotechnologies, Stanley Pharmaceuticals, QLT Phototherapeutics, and Stemcell Technologies. Various public and private research organizations include the Center for Molecular Medicine and Therapeutics, the Biotechnology Laboratory at the University of British Columbia, the BC Cancer Research Center, the Canadian HIV Trials Network, and the Vaccine Evaluation Center. Thus, the development of the biopharmaceutical industry in the country will bolster the market growth during the forecast period

Asia Pacific is expected to be the fastest-growing market in the coming years. In Asia Pacific, China is the largest market for fill finish manufacturing. The growth of the market is primarily attributed to the rising technological advancements in fill finish manufacturing processes in China, increasing developments by the market players, the biopharmaceutical industry's expansion, and the growing prevalence of chronic diseases. There are more than 500 biological product/biopharmaceutical companies in China. Most of those involved in R&D were established by returnees from abroad or by Western/joint venture companies. Although estimates vary widely, analysts believe that the Chinese government spends more than US$ 600 million annually on biotech R&D through its funding initiatives. China's national and local governments also invest in quasi-venture capital companies that invest in IT enterprises. The market players are expanding their business through organic and inorganic growth strategies. For instance, WuXi Biologics increased the capacity of prefilled syringes (PFS) to 17 million units yearly in June 2022 by opening its drug product factory in Wuxi, China. The most recent D.P. facility operated by WuXi Bio, a contract development manufacturing organization (CDMO), is called DP5, and it has an advanced isolator filling line for reliable, continuous filling services. According to the company, this provides PFS with a variety of volume delivery options, including 1.25 mL, 3 mL, 1 mL, and 1 mL.

ClinicalTrails.com, Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA) are a few key primary and secondary sources referred to while preparing the report on the fill finish manufacturing market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the fill finish manufacturing market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the fill finish manufacturing market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the fill finish manufacturing market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Fill Finish Manufacturing Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Fill Finish Manufacturing Market - Key Industry Dynamics

  • 5.1 Fill Finish Manufacturing Market - Key Industry Dynamics
  • 5.2 Key Market Drivers
    • 5.2.1 Growing Adoption of Prefilled Syringes for Parenteral Administration
    • 5.2.2 Elevating Demand for Biologics
  • 5.3 Key Market Restraints
    • 5.3.1 Growing Competition in Biopharmaceutical Contract Manufacturing Industry
  • 5.4 Key Market Opportunities
    • 5.4.1 Low Business Costs in Emerging Markets
  • 5.5 Key Future Trends
    • 5.5.1 Single-Use Systems for Aseptic Fill Finish
  • 5.6 Impact of Drivers and Restraints:

6. Fill Finish Manufacturing Market - Global Market Analysis

7. Fill Finish Manufacturing Market Analysis - Product

  • 7.1 Consumables
    • 7.1.1 Overview
    • 7.1.2 Consumables Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Instruments
    • 7.2.1 Overview
    • 7.2.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)

8. Fill Finish Manufacturing Market Analysis - Modality

  • 8.1 Recombinant Proteins
    • 8.1.1 Overview
    • 8.1.2 Recombinant Proteins Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Monoclonal Antibodies
    • 8.2.1 Overview
    • 8.2.2 Monoclonal Antibodies Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Vaccines
    • 8.3.1 Overview
    • 8.3.2 Vaccines Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Cell Therapies and Biological Therapies
    • 8.4.1 Overview
    • 8.4.2 Cell Therapies and Biological Therapies Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Gene Therapies
    • 8.5.1 Overview
    • 8.5.2 Gene Therapies Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. Fill Finish Manufacturing Market Analysis - End User

  • 9.1 Contract Manufacturing Organizations
    • 9.1.1 Overview
    • 9.1.2 Contract Manufacturing Organizations Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Biopharmaceutical Companies
    • 9.2.1 Overview
    • 9.2.2 Biopharmaceutical Companies Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

10. Fill Finish Manufacturing Market - Geographical Analysis

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 North America Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
      • 10.2.1.1 North America Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By Product
        • 10.2.1.1.1 North America Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By Consumables
      • 10.2.1.2 North America Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By Modality
      • 10.2.1.3 North America Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By End User
    • 10.2.2 North America Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By Country
      • 10.2.2.1 US
      • 10.2.2.2 US Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
        • 10.2.2.2.1 United States Fill Finish Manufacturing Market Breakdown by Product
        • 10.2.2.2.1.1 United States Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.2.2.2.2 United States Fill Finish Manufacturing Market Breakdown by Modality
        • 10.2.2.2.3 United States Fill Finish Manufacturing Market Breakdown by End User
      • 10.2.2.3 Canada
      • 10.2.2.4 Canada Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
        • 10.2.2.4.1 Canada Fill Finish Manufacturing Market Breakdown by Product
        • 10.2.2.4.1.1 Canada Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.2.2.4.2 Canada Fill Finish Manufacturing Market Breakdown by Modality
        • 10.2.2.4.3 Canada Fill Finish Manufacturing Market Breakdown by End User
      • 10.2.2.5 Mexico
      • 10.2.2.6 Mexico Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
        • 10.2.2.6.1 Mexico Fill Finish Manufacturing Market Breakdown by Product
        • 10.2.2.6.1.1 Mexico Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.2.2.6.2 Mexico Fill Finish Manufacturing Market Breakdown by Modality
        • 10.2.2.6.3 Mexico Fill Finish Manufacturing Market Breakdown by End User
  • 10.3 Europe
    • 10.3.1 Europe Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
      • 10.3.1.1 Europe Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By Product
        • 10.3.1.1.1 Europe Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By Consumables
      • 10.3.1.2 Europe Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By Modality
    • 10.3.2 Europe Fill Finish Manufacturing Market Breakdown by End User
      • 10.3.2.1 Europe Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By End User
    • 10.3.3 Europe Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By Country
      • 10.3.3.1 United Kingdom
      • 10.3.3.2 United Kingdom Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
        • 10.3.3.2.1 United Kingdom Fill Finish Manufacturing Market Breakdown by Product
        • 10.3.3.2.1.1 United Kingdom Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.3.3.2.2 United Kingdom Fill Finish Manufacturing Market Breakdown by Modality
        • 10.3.3.2.3 United Kingdom Fill Finish Manufacturing Market Breakdown by End User
      • 10.3.3.3 Germany
      • 10.3.3.4 Germany Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
        • 10.3.3.4.1 Germany Fill Finish Manufacturing Market Breakdown by Product
        • 10.3.3.4.1.1 Germany Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.3.3.4.2 Germany Fill Finish Manufacturing Market Breakdown by Modality
        • 10.3.3.4.3 Germany Fill Finish Manufacturing Market Breakdown by End User
      • 10.3.3.5 France
      • 10.3.3.6 France Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
        • 10.3.3.6.1 France Fill Finish Manufacturing Market Breakdown by Product
        • 10.3.3.6.1.1 France Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.3.3.6.2 France Fill Finish Manufacturing Market Breakdown by Modality
        • 10.3.3.6.3 France Fill Finish Manufacturing Market Breakdown by End User
      • 10.3.3.7 Italy
        • 10.3.3.7.1 Italy Fill Finish Manufacturing Market Breakdown by Product
        • 10.3.3.7.1.1 Italy Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.3.3.7.2 Italy Fill Finish Manufacturing Market Breakdown by Modality
        • 10.3.3.7.3 Italy Fill Finish Manufacturing Market Breakdown by End User
      • 10.3.3.8 Spain
      • 10.3.3.9 Spain Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
        • 10.3.3.9.1 Spain Fill Finish Manufacturing Market Breakdown by Product
        • 10.3.3.9.1.1 Spain Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.3.3.9.2 Spain Fill Finish Manufacturing Market Breakdown by Modality
        • 10.3.3.9.3 Spain Fill Finish Manufacturing Market Breakdown by End User
      • 10.3.3.10 Rest of Europe
      • 10.3.3.11 Rest of Europe Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
        • 10.3.3.11.1 Rest of Europe Fill Finish Manufacturing Market Breakdown by Product
        • 10.3.3.11.1.1 Rest of Europe Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.3.3.11.2 Rest of Europe Fill Finish Manufacturing Market Breakdown by Modality
        • 10.3.3.11.3 Rest of Europe Fill Finish Manufacturing Market Breakdown by End User
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
      • 10.4.1.1 Asia Pacific Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By Product
        • 10.4.1.1.1 Asia Pacific Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By Consumables
      • 10.4.1.2 Asia Pacific Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By Modality
      • 10.4.1.3 Asia Pacific Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By End User
    • 10.4.2 Asia Pacific Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By Country
      • 10.4.2.1 China
      • 10.4.2.2 China Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
        • 10.4.2.2.1 China Fill Finish Manufacturing Market Breakdown by Product
        • 10.4.2.2.1.1 China Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.4.2.2.2 China Fill Finish Manufacturing Market Breakdown by Modality
        • 10.4.2.2.3 China Fill Finish Manufacturing Market Breakdown by End User
      • 10.4.2.3 Japan
        • 10.4.2.3.1 Japan Fill Finish Manufacturing Market Breakdown by Product
        • 10.4.2.3.1.1 Japan Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.4.2.3.2 Japan Fill Finish Manufacturing Market Breakdown by Modality
        • 10.4.2.3.3 Japan Fill Finish Manufacturing Market Breakdown by End User
      • 10.4.2.4 India
      • 10.4.2.5 India Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
        • 10.4.2.5.1 India Fill Finish Manufacturing Market Breakdown by Product
        • 10.4.2.5.1.1 India Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.4.2.5.2 India Fill Finish Manufacturing Market Breakdown by Modality
        • 10.4.2.5.3 India Fill Finish Manufacturing Market Breakdown by End User
      • 10.4.2.6 Australia
      • 10.4.2.7 Australia Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
        • 10.4.2.7.1 Australia Fill Finish Manufacturing Market Breakdown by Product
        • 10.4.2.7.1.1 Australia Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.4.2.7.2 Australia Fill Finish Manufacturing Market Breakdown by Modality
        • 10.4.2.7.3 Australia Fill Finish Manufacturing Market Breakdown by End User
      • 10.4.2.8 South Korea
      • 10.4.2.9 South Korea Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
        • 10.4.2.9.1 South Korea Fill Finish Manufacturing Market Breakdown by Product
        • 10.4.2.9.1.1 South Korea Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.4.2.9.2 South Korea Fill Finish Manufacturing Market Breakdown by Modality
        • 10.4.2.9.3 South Korea Fill Finish Manufacturing Market Breakdown by End User
      • 10.4.2.10 Rest of APAC
      • 10.4.2.11 Rest of APAC Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
        • 10.4.2.11.1 Rest of APAC Fill Finish Manufacturing Market Breakdown by Product
        • 10.4.2.11.1.1 Rest of APAC Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.4.2.11.2 Rest of APAC Fill Finish Manufacturing Market Breakdown by Modality
        • 10.4.2.11.3 Rest of APAC Fill Finish Manufacturing Market Breakdown by End User
  • 10.5 Middle East and Africa
    • 10.5.1 Middle East and Africa Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
      • 10.5.1.1 Middle East and Africa Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By Product
        • 10.5.1.1.1 Middle East and Africa Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By Consumables
      • 10.5.1.2 Middle East and Africa Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By Modality
      • 10.5.1.3 Middle East and Africa Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By End User
    • 10.5.2 Middle East and Africa Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By Country
      • 10.5.2.1 South Africa
      • 10.5.2.2 South Africa Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
        • 10.5.2.2.1 South Africa Fill Finish Manufacturing Market Breakdown by Product
        • 10.5.2.2.1.1 South Africa Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.5.2.2.2 South Africa Fill Finish Manufacturing Market Breakdown by Modality
        • 10.5.2.2.3 South Africa Fill Finish Manufacturing Market Breakdown by End User
      • 10.5.2.3 Saudi Arabia
      • 10.5.2.4 Saudi Arabia Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
        • 10.5.2.4.1 Saudi Arabia Fill Finish Manufacturing Market Breakdown by Product
        • 10.5.2.4.1.1 Saudi Arabia Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.5.2.4.2 Saudi Arabia Fill Finish Manufacturing Market Breakdown by Modality
        • 10.5.2.4.3 Saudi Arabia Fill Finish Manufacturing Market Breakdown by End User
      • 10.5.2.5 United Arab Emirates
      • 10.5.2.6 United Arab Emirates Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
        • 10.5.2.6.1 United Arab Emirates Fill Finish Manufacturing Market Breakdown by Product
        • 10.5.2.6.1.1 United Arab Emirates Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.5.2.6.2 United Arab Emirates Fill Finish Manufacturing Market Breakdown by Modality
        • 10.5.2.6.3 United Arab Emirates Fill Finish Manufacturing Market Breakdown by End User
      • 10.5.2.7 Rest of Middle East and Africa
      • 10.5.2.8 Rest of Middle East and Africa Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
        • 10.5.2.8.1 Rest of Middle East and Africa Fill Finish Manufacturing Market Breakdown by Product
        • 10.5.2.8.1.1 Rest of Middle East and Africa Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.5.2.8.2 Rest of Middle East and Africa Fill Finish Manufacturing Market Breakdown by Modality
        • 10.5.2.8.3 Rest of Middle East and Africa Fill Finish Manufacturing Market Breakdown by End User
  • 10.6 South and Central America
    • 10.6.1 South and Central America Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
      • 10.6.1.1 South and Central America Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By Product
        • 10.6.1.1.1 South and Central America Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By Consumables
      • 10.6.1.2 South and Central America Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By Modality
      • 10.6.1.3 South and Central America Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By End User
    • 10.6.2 South and Central America Fill Finish Manufacturing Market Revenue and Forecasts and Analysis - By Country
      • 10.6.2.1 Brazil
      • 10.6.2.2 Brazil Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
        • 10.6.2.2.1 Brazil Fill Finish Manufacturing Market Breakdown by Product
        • 10.6.2.2.1.1 Brazil Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.6.2.2.2 Brazil Fill Finish Manufacturing Market Breakdown by Modality
        • 10.6.2.2.3 Brazil Fill Finish Manufacturing Market Breakdown by End User
      • 10.6.2.3 Argentina
      • 10.6.2.4 Argentina Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
        • 10.6.2.4.1 Argentina Fill Finish Manufacturing Market Breakdown by Product
        • 10.6.2.4.1.1 Argentina Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.6.2.4.2 Argentina Fill Finish Manufacturing Market Breakdown by Modality
        • 10.6.2.4.3 Argentina Fill Finish Manufacturing Market Breakdown by End User
      • 10.6.2.5 Rest of South and Central America
      • 10.6.2.6 Rest of South and Central America Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
        • 10.6.2.6.1 Rest of South and Central America Fill Finish Manufacturing Market Breakdown by Product
        • 10.6.2.6.1.1 Rest of South and Central America Fill Finish Manufacturing Market Breakdown by Consumables
        • 10.6.2.6.2 Rest of South and Central America Fill Finish Manufacturing Market Breakdown by Modality
        • 10.6.2.6.3 Rest of South and Central America Fill Finish Manufacturing Market Breakdown by End User

11. Fill Finish Manufacturing Market - Impact of COVID-19 Pandemic

  • 11.1 Pre & Post Covid-19 Impact

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in The Fill Finish Manufacturing Market, 2020-2023
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 IMA Industria Macchine Automatiche SpA
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Nipro Medical Europe NV
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Key Developments
    • 13.2.5 Financial Overview
    • 13.2.6 SWOT Analysis
    • 13.2.7 Key Developments
  • 13.3 Maquinaria Industrial Dara SL
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Groninger and Co GmbH
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 SGD SA
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Optima Packaging Group Gmbh
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 NNE AS
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Product & Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Stevanato Group SpA
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Syntegon Technology GmbH
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 West Pharmaceutical Services Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Gerresheimer AG
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Schott AG
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 Becton Dickinson and Co
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제